Thermo Fisher Scientific Inc. (NYSE:TMO)’s share price reached a new 52-week high on Wednesday . The company traded as high as $155.17 and last traded at $154.68, with a volume of 401,869 shares. The stock had previously closed at $154.38.

A number of brokerages have commented on TMO. Mizuho increased their target price on Thermo Fisher Scientific from $150.00 to $160.00 and gave the company a “buy” rating in a report on Monday, April 4th. Jefferies Group cut Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Friday, April 29th. Leerink Swann reissued an “outperform” rating on shares of Thermo Fisher Scientific in a report on Monday, March 21st. Zacks Investment Research cut Thermo Fisher Scientific from a “hold” rating to a “sell” rating in a report on Tuesday, April 5th. Finally, Morgan Stanley reissued a “buy” rating on shares of Thermo Fisher Scientific in a report on Thursday, May 19th. Three equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $155.43.

The company has a 50-day moving average of $150.24 and a 200-day moving average of $141.71. The stock has a market capitalization of $62.07 billion and a price-to-earnings ratio of 31.74.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings data on Thursday, April 28th. The company reported $1.80 earnings per share for the quarter, beating analysts’ consensus estimates of $1.74 by $0.06. The firm earned $4.29 billion during the quarter, compared to analysts’ expectations of $4.11 billion. During the same period in the previous year, the company earned $1.63 earnings per share. The business’s quarterly revenue was up 9.6% on a year-over-year basis. Equities research analysts predict that Thermo Fisher Scientific Inc. will post $8.13 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Monday, October 17th. Stockholders of record on Thursday, September 15th will be paid a $0.15 dividend. The ex-dividend date is Tuesday, September 13th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.38%.

In other news, SVP Daniel P. Shine sold 6,013 shares of the company’s stock in a transaction dated Tuesday, April 26th. The shares were sold at an average price of $146.00, for a total value of $877,898.00. Following the sale, the senior vice president now owns 27,892 shares in the company, valued at approximately $4,072,232. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Thomas W. Loewald sold 15,000 shares of the company’s stock in a transaction dated Thursday, June 2nd. The shares were sold at an average price of $152.84, for a total transaction of $2,292,600.00. Following the completion of the sale, the senior vice president now owns 49,169 shares in the company, valued at approximately $7,514,989.96. The disclosure for this sale can be found here.

Several large investors recently modified their holdings of the stock. MUFG Americas raised its stake in shares of Thermo Fisher Scientific by 6.9% in the third quarter. MUFG Americas now owns 26,338 shares of the company’s stock worth $3,222,000 after buying an additional 1,702 shares during the period. Swiss National Bank raised its stake in shares of Thermo Fisher Scientific by 1.9% in the fourth quarter. Swiss National Bank now owns 723,832 shares of the company’s stock worth $102,676,000 after buying an additional 13,500 shares during the period. Sei Investments Co. raised its stake in shares of Thermo Fisher Scientific by 175.6% in the fourth quarter. Sei Investments Co. now owns 140,932 shares of the company’s stock worth $19,992,000 after buying an additional 89,797 shares during the period. Denver Investment Advisors LLC raised its stake in shares of Thermo Fisher Scientific by 555.6% in the fourth quarter. Denver Investment Advisors LLC now owns 16,194 shares of the company’s stock worth $2,298,000 after buying an additional 13,724 shares during the period. Finally, First Trust Advisors LP raised its stake in shares of Thermo Fisher Scientific by 51.8% in the fourth quarter. First Trust Advisors LP now owns 276,223 shares of the company’s stock worth $39,182,000 after buying an additional 94,302 shares during the period.

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.